JP2023533768A5 - - Google Patents
Info
- Publication number
- JP2023533768A5 JP2023533768A5 JP2023501609A JP2023501609A JP2023533768A5 JP 2023533768 A5 JP2023533768 A5 JP 2023533768A5 JP 2023501609 A JP2023501609 A JP 2023501609A JP 2023501609 A JP2023501609 A JP 2023501609A JP 2023533768 A5 JP2023533768 A5 JP 2023533768A5
- Authority
- JP
- Japan
- Prior art keywords
- specific binding
- binding molecule
- fragment
- nucleic acid
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2010652.2A GB202010652D0 (en) | 2020-07-10 | 2020-07-10 | Anti-tau antibodies |
| GB2010652.2 | 2020-07-10 | ||
| PCT/EP2021/069160 WO2022008719A1 (en) | 2020-07-10 | 2021-07-09 | Anti-tau antibodies |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023533768A JP2023533768A (ja) | 2023-08-04 |
| JP2023533768A5 true JP2023533768A5 (https=) | 2024-05-09 |
| JP7796719B2 JP7796719B2 (ja) | 2026-01-09 |
Family
ID=72140057
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023501609A Active JP7796719B2 (ja) | 2020-07-10 | 2021-07-09 | 抗タウ抗体 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230257452A1 (https=) |
| EP (1) | EP4178980A1 (https=) |
| JP (1) | JP7796719B2 (https=) |
| KR (1) | KR20230038721A (https=) |
| CN (1) | CN116194479A (https=) |
| AU (1) | AU2021306653A1 (https=) |
| CA (1) | CA3185175A1 (https=) |
| GB (1) | GB202010652D0 (https=) |
| TW (1) | TWI912331B (https=) |
| WO (1) | WO2022008719A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20250147051A1 (en) * | 2022-01-12 | 2025-05-08 | Gtinvent Limited | Method for detecting a tau protein in a saliva sample |
| KR20240134175A (ko) * | 2022-01-12 | 2024-09-06 | 지틴벤트 리미티드 | 샘플에서 타우(tau) 단백질 단편을 검출하기 위한 방법 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9506197D0 (en) | 1995-03-27 | 1995-05-17 | Hoffmann La Roche | Inhibition of tau-tau association. |
| GB0106953D0 (en) | 2001-03-20 | 2001-05-09 | Univ Aberdeen | Neufofibrillary labels |
| US20140303041A1 (en) * | 2004-04-15 | 2014-10-09 | University Of Florida Research Foundation Inc. | In vitro diagnostic devices for nervous system injury and other neural disorders |
| ES2349322T7 (es) | 2006-03-29 | 2019-10-17 | Wista Lab Ltd | Sales de 3,7-diamino-10H-fenotiazina y su utilización |
| WO2007110630A1 (en) | 2006-03-29 | 2007-10-04 | Wista Laboratories Ltd. | Thioninium compounds and their use |
| JP5898701B2 (ja) | 2011-02-11 | 2016-04-13 | ウィスタ ラボラトリーズ リミテッド | フェノチアジンジアミニウム塩およびそれらの使用 |
| CA2896066C (en) * | 2012-12-21 | 2022-07-12 | Biogen Ma Inc. | Human anti-tau antibodies |
| GB201312226D0 (en) * | 2013-07-08 | 2013-08-21 | Adx Neurosciences | Improved antibodies |
| BR112016010454A2 (pt) * | 2013-11-27 | 2017-12-05 | Ipierian Inc | métodos para tratar uma taupatia |
| CA3032692A1 (en) | 2016-08-09 | 2018-02-15 | Eli Lilly And Company | Combination antibody therapy for the treatment of neurodegenerative diseases |
| UA128383C2 (uk) * | 2016-12-07 | 2024-07-03 | Дженентек, Інк. | Антитіло до тау-білка та спосіб його застосування |
| EP3601337A1 (en) * | 2017-03-28 | 2020-02-05 | Genentech, Inc. | Methods of treating neurodegenerative diseases |
| US20250147051A1 (en) * | 2022-01-12 | 2025-05-08 | Gtinvent Limited | Method for detecting a tau protein in a saliva sample |
-
2020
- 2020-07-10 GB GBGB2010652.2A patent/GB202010652D0/en not_active Ceased
-
2021
- 2021-07-09 TW TW110125334A patent/TWI912331B/zh active
- 2021-07-09 KR KR1020237003616A patent/KR20230038721A/ko active Pending
- 2021-07-09 WO PCT/EP2021/069160 patent/WO2022008719A1/en not_active Ceased
- 2021-07-09 JP JP2023501609A patent/JP7796719B2/ja active Active
- 2021-07-09 EP EP21739721.5A patent/EP4178980A1/en active Pending
- 2021-07-09 CA CA3185175A patent/CA3185175A1/en active Pending
- 2021-07-09 US US18/004,772 patent/US20230257452A1/en active Pending
- 2021-07-09 CN CN202180062368.9A patent/CN116194479A/zh active Pending
- 2021-07-09 AU AU2021306653A patent/AU2021306653A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018524001A5 (https=) | ||
| NZ748983A (en) | Antibodies specific for hyperphosphorylated tau and methods of use thereof | |
| JP2022541539A5 (https=) | ||
| JP2016503065A5 (https=) | ||
| JP2018531580A5 (https=) | ||
| RU2019118922A (ru) | Моноклональные антитела к альфа-синуклеину для предотвращения агрегации тау-белка | |
| JP7109467B2 (ja) | タウに特異的に結合する結合分子 | |
| JP2023533768A5 (https=) | ||
| JP2013524774A5 (https=) | ||
| RU2015141418A (ru) | Антитела, связывающие il-4 и/или il-13, и их применение | |
| JP2021524267A5 (https=) | ||
| JP2020513804A5 (https=) | ||
| JP2018505651A5 (https=) | ||
| IL266911B2 (en) | Anti-tau antibodies and uses thereof in treating tauopathy, retaining or increasing cognitive memory capacity or slowing memory loss | |
| JP2013525266A5 (https=) | ||
| JP2020529473A5 (https=) | ||
| JP2023071956A5 (https=) | ||
| FI3303386T3 (fi) | Tau-vasta-aineita ja käyttömenetelmiä | |
| JP2013500940A5 (https=) | ||
| JP2018535650A5 (https=) | ||
| JP2018516853A5 (https=) | ||
| US20220273779A1 (en) | Tau peptide antigens and antibodies binding thereto for the treatment of tauopathies | |
| CN115461364A (zh) | 一种抗新型冠状病毒的单克隆抗体及其应用 | |
| JP2017532288A5 (https=) | ||
| Lindberg et al. | A truncated and dimeric format of an affibody library on bacteria enables FACS‐mediated isolation of amyloid‐beta aggregation inhibitors with subnanomolar affinity |